VANDA PHARMACEUTICALS INC's ticker is VNDA and the CUSIP is 921659108. A total of 132 filers reported holding VANDA PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is 2.40 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2017 | $9,546,000 | +60.8% | 628,000 | +89.3% | 0.07% | +50.0% |
Q3 2017 | $5,937,000 | +59.1% | 331,700 | +44.9% | 0.05% | +39.4% |
Q2 2017 | $3,731,000 | +86.1% | 228,900 | +59.8% | 0.03% | +83.3% |
Q1 2017 | $2,005,000 | -74.7% | 143,200 | -71.2% | 0.02% | -75.3% |
Q4 2016 | $7,921,000 | +1240.3% | 496,600 | +1298.9% | 0.07% | +1116.7% |
Q3 2016 | $591,000 | +23.1% | 35,500 | -17.2% | 0.01% | +50.0% |
Q2 2016 | $480,000 | +300.0% | 42,900 | +197.9% | 0.00% | +300.0% |
Q1 2016 | $120,000 | +14.3% | 14,400 | +27.4% | 0.00% | 0.0% |
Q4 2015 | $105,000 | -52.1% | 11,300 | -41.8% | 0.00% | -66.7% |
Q3 2015 | $219,000 | +15.9% | 19,400 | +30.2% | 0.00% | +50.0% |
Q2 2015 | $189,000 | +43.2% | 14,900 | +4.9% | 0.00% | 0.0% |
Q1 2015 | $132,000 | -11.4% | 14,200 | +36.5% | 0.00% | 0.0% |
Q4 2014 | $149,000 | -93.7% | 10,400 | -94.5% | 0.00% | -95.0% |
Q4 2013 | $2,358,000 | +929.7% | 189,980 | +809.0% | 0.04% | +900.0% |
Q3 2013 | $229,000 | -96.3% | 20,900 | -97.3% | 0.00% | -96.8% |
Q2 2013 | $6,178,000 | – | 764,547 | – | 0.12% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Consonance Capital Management LP | 4,658,759 | $121,733,000 | 8.95% |
Palo Alto Investors LP | 4,155,670 | $108,588,000 | 5.78% |
Stonepine Capital Management, LLC | 220,848 | $5,771,000 | 5.07% |
Birchview Capital, LP | 80,000 | $2,090,000 | 1.98% |
EAM Global Investors LLC | 75,310 | $1,968,000 | 1.08% |
Atika Capital Management LLC | 130,000 | $3,397,000 | 1.00% |
EAM Investors, LLC | 110,806 | $2,895,000 | 0.79% |
UNIVERSITY OF NOTRE DAME DU LAC | 97,521 | $2,548,000 | 0.62% |
ALGERT GLOBAL LLC | 76,204 | $1,991,000 | 0.56% |
361 CAPITAL LLC | 85,885 | $2,244,000 | 0.46% |